ROCKVILLE, Md. – May 27, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the release of a three-part series of scientific ...
Association for Molecular Pathology publishes best practice recommendations for clinical HRD testing
ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations ...
This is the second article in Microbiologics’ series on Optimal QC in the Clinical Laboratory. In a previous article, we highlighted the importance of external quality control products for QC in the ...
Furthermore, EHRs serve as the primary interface for clinicians and laboratories to order tests and receive results, but molecular profiling results and their interpretation often exist outside of the ...
In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...
Labroots is excited to host the 16th Annual Clinical Diagnostics & Research Virtual Event Series on November 12, 2025. This premier online event unites clinicians, lab professionals, and researchers ...
AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease ...
The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...
NASHVILLE, Tenn., June 17, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (“iMDx” or the “Company”), (Nasdaq: IMDX), formerly known as Oncocyte Corporation (Nasdaq: OCX), has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results